Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sedation with Midazolam vs Combination with Dexmedetomidine or Magnesium in TBI
NCT05340803Phase 3Not yet recruiting
- Sponsor
- Assiut University
- Start
- Nov 2022
- Primary completion
- Jan 2025
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of dexmedetomidine, magnesium sulfate in traumatic brain injury (TBI), sponsored by Assiut University. Planned start Nov 2022; status: not yet recruiting.
02
Drugs
dexmedetomidinemagnesium sulfate
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT05340803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05340803.